DiabTec - Crunchbase Company Profile & Funding

Overview

DiabTec

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About DiabTec

CB Rank

1459784

DiabTec is a unit of Julphar that manufactures recombinant human Insulin API services.

Acquired by

KELIX bio

Private

Health Care

Manufacturing

Details

Sub-Organization of

Julphar

Legal Name

DiabTec, LLC.

Operating Status

Active

Company Type

For Profit

About the Company

DiabTec is a unit of Julphar that manufactures recombinant human Insulin API services.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

DiabTec

was acquired by

KELIX bio

obfuscation

Transaction Name

DiabTec acquired by KELIX bio

Acquired by

KELIX bio

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

News

Technology

View Tech Report

Lists Featuring This Company

Health Care Acquired Companies (Top 10K)

9,918 Number of Organizations • $304.4B Total Funding Amount • 11,893 Number of Investors

Sub-Organizations

Frequently Asked Questions